ArticlePostepy dermatologii i alergologii2022

Efficacy of guselkumab compared with adalimumab for psoriasis: a meta-analysis of randomized controlled studies.

Hongyi Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.